Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001080815 | SCV000632193 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000711112 | SCV000841440 | benign | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000711112 | SCV002545326 | benign | not provided | 2022-07-01 | criteria provided, single submitter | clinical testing | CACNA1H: BS1, BS2 |
Fulgent Genetics, |
RCV002506315 | SCV002808977 | likely benign | Epilepsy, childhood absence, susceptibility to, 6; Hyperaldosteronism, familial, type IV | 2022-04-30 | criteria provided, single submitter | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000711112 | SCV001798600 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001702500 | SCV001927600 | benign | not specified | no assertion criteria provided | clinical testing |